129 related articles for article (PubMed ID: 3735703)
1. Advanced ovarian cancer treated by intraperitoneal immunotherapy with OK-432.
Kawagoe K; Masuda H
Jpn J Clin Oncol; 1986 Jun; 16(2):137-42. PubMed ID: 3735703
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of induction of endogenous tumor necrosis factor in ascites of ovarian cancer patients by OK-432, a streptococcal preparation.
Mori H; Itoh N; Tamaya T
Immunopharmacol Immunotoxicol; 1989; 11(1):33-53. PubMed ID: 2503555
[TBL] [Abstract][Full Text] [Related]
3. New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destruction.
Katano M; Torisu M
Surgery; 1983 Mar; 93(3):365-73. PubMed ID: 6600854
[TBL] [Abstract][Full Text] [Related]
4. [Management of malignant ascites by intraperitoneal injection of OK-432. Possible mechanism of the reduction of original tumor mass volume].
Katano M; Mizoguchi T; Yamamoto H; Hisatsugu T; Torisu M
Nihon Geka Gakkai Zasshi; 1987 Dec; 88(12):1676-83. PubMed ID: 3447033
[TBL] [Abstract][Full Text] [Related]
5. [The effect of intraperitoneal administration of OK-432 with recombinant interleukin-2 to patients with peritonitis carcinomatosa of recurrent gynecological cancer and changes in ascitic lymphocyte subsets].
Kanaoka Y; Umesaki N
Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):489-96. PubMed ID: 2056223
[TBL] [Abstract][Full Text] [Related]
6. Pseudomyxoma peritonei: effect of chronic continuous immunotherapy with a streptococcal preparation, OK-432 after surgery.
Fukuma K; Matsuura K; Shibata S; Nakahara K; Fujisaki S; Maeyama M
Acta Obstet Gynecol Scand; 1986; 65(2):133-7. PubMed ID: 3727940
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil-mediated tumor cell destruction in cancer ascites.
Katano M; Torisu M
Cancer; 1982 Jul; 50(1):62-8. PubMed ID: 7083126
[TBL] [Abstract][Full Text] [Related]
8. New approach to management of malignant ascites with streptococcal preparation OK-432. III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils.
Hayashi Y; Torisu M
Surgery; 1990 Jan; 107(1):74-84. PubMed ID: 2404351
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil-mediated tumor cell destruction in cancer ascites. II. A OK-432 attracts killer neutrophils through activation of complement C5.
Fujimura T; Torisu M
Clin Immunol Immunopathol; 1987 May; 43(2):174-84. PubMed ID: 3105938
[TBL] [Abstract][Full Text] [Related]
10. Effects of intraperitoneal administration of OK-432 for patients with advanced cancer.
Toge T; Yamada H; Aratani K; Kameda A; Kuroi K; Hisamatsu K; Hattori T
Jpn J Surg; 1985 Jul; 15(4):260-5. PubMed ID: 2932585
[TBL] [Abstract][Full Text] [Related]
11. [The management of malignant ascites with a streptococcal preparation, OK-432: relation between the clinical effect and auto-tumor cell killing activity by OK-432-induced ascites-derived lymphocytes].
Katano M; Yamamoto H; Mizoguchi T; Hidaka K; Hisatsugu T; Torisu M
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2464-8. PubMed ID: 3497612
[TBL] [Abstract][Full Text] [Related]
12. [Whole abdominal irradiation of ovarian cancer in combined treatment with OK-432 picibanil].
Morita S; Arai T; Tsunemoto H
Gan No Rinsho; 1986 Jan; 32(1):71-5. PubMed ID: 3005691
[TBL] [Abstract][Full Text] [Related]
13. [Effect of immunotherapy using the non-specific immunopotentiator OK-432 in malignant ovarian tumors--selecting appropriate cases for immunotherapy].
Nishida Y; Sakakibara K; Kano T; Ohta M; Tomoda Y
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jul; 38(7):1017-25. PubMed ID: 3746020
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effect of the streptococcal preparation OK-432 in a murine model of ovarian cancer.
Lichtenstein A
Cancer Immunol Immunother; 1987; 24(2):172-7. PubMed ID: 3829052
[TBL] [Abstract][Full Text] [Related]
15. Induction of endogenous cytokines in ascites of patients with ovarian cancer by OK-432, a streptococcal preparation.
Mori H; Itoh N; Yamada Y; Tamaya T
Asia Oceania J Obstet Gynaecol; 1989 Sep; 15(3):281-9. PubMed ID: 2512905
[TBL] [Abstract][Full Text] [Related]
16. Treatment of cancer ascites by intraperitoneal administration of a streptococcal preparation OK-432 with fresh human complement--role of complement-derived chemotactic factor to neutrophils.
Kondo M; Kato H; Yoshikawa T; Sugino S
Int J Immunopharmacol; 1986; 8(7):715-21. PubMed ID: 3536766
[TBL] [Abstract][Full Text] [Related]
17. [Nursing of a patient with ascites being treated with OK-432].
Yamashita I; Hidaka M; Ikegawa H; Yuhara K; Mori C
Kango Gijutsu; 1989 Mar; 35(4):412-5. PubMed ID: 2754876
[No Abstract] [Full Text] [Related]
18. [Treatment of malignant ascites. I. Clinical studies on intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)].
Katano M
Fukuoka Igaku Zasshi; 1981 Oct; 72(10):532-42. PubMed ID: 7327498
[No Abstract] [Full Text] [Related]
19. [Treatment of malignant ascites. II. Immunological studies on disappearance of ascites by intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)].
Katano M
Fukuoka Igaku Zasshi; 1981 Oct; 72(10):543-55. PubMed ID: 7327499
[No Abstract] [Full Text] [Related]
20. [Intraperitoneal administration of OK-432 and rIL-2 in a case of peritonitis carcinomatosa with chronic renal failure].
Kanaoka Y; Umesaki N; Kawabata M; Tsuda H; Sugawa T
Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):1027-31. PubMed ID: 2391442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
